PACS2 and PSS1 regulations in AD were reported in a study by Hedskog et al. showing enhanced PACS2 and PSS1 protein levels in AD transgenic mice expressing Swe/LDN FAD mutations [54]. This evidence concerns the gene PTDSS1 and Alzheimer disease.